Unlocking Opportunities in the Cough Hypersensitivity Syndrome Market: Key Growth Trends and Forecast Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Growth Potential of the Cough Hypersensitivity Syndrome Market, and How Will It Perform by 2034?
The market size for cough hypersensitivity syndrome has seen significant growth lately. The market, which was worth $10.36 billion in 2024, is projected to increase to $11.03 billion in 2025 with a compound annual growth rate (CAGR) of 6.4%. Factors such as heightened awareness, the use of telemedicine and remote monitoring, public health campaigns, and funding for research have contributed to the growth seen in the past years.
Over the coming years, a compelling growth is predicted for the cough hypersensitivity syndrome market. By 2029, it’s projected to accelerate to $14.65 billion, at a compound annual growth rate (CAGR) of 7.4%. The contributing factors to this growth during the forecast period include access to global health resources, patient advocacy and assistance, and enhancements in the quality of life. Anticipated trends for this timeframe include advanced diagnosis and screening methods, customized therapy strategies, and innovative medicines.
What Key Drivers Are Accelerating the Growth of the cough hypersensitivity syndrome Market During the Forecast Period?
The increasing incidence of chronic respiratory diseases is anticipated to stimulate the expansion of the cough hypersensitivity syndrome market. Chronic respiratory diseases (CRDs) are long-lasting illnesses that impair the lungs and airways, leading to ongoing breathing challenges and a gradual decrease in lung function. Treatments for cough hypersensitivity syndrome ease discomfort, bolster respiratory health and enhance the quality of life for patients battling chronic respiratory diseases like asthma. To illustrate, data from the Australian Institute of Health and Welfare in June 2023 revealed that almost one-third (30%) of Australians, equivalent to 7.5 million people, are living with chronic respiratory diseases. In addition, according to the US-based National Center for Health Statistics (NCHS), the instances of current asthma in US adults aged 18 and above rose from 8.4% in 2021 to 8.7% in 2022. Additionally, there was an increase in asthma episodes within the past year for adults in the same age bracket, rising from 3.3% in 2021 to 3.7% in 2022. Hence, the escalating incidence of chronic respiratory diseases is driving the growth of the cough hypersensitivity syndrome market. The surge in cigarette smokers is also projected to boost the cough hypersensitivity syndrome market’s growth. Cigarette smokers refer to individuals who habitually smoke cigarettes, which involves inhaling smoke from burning tobacco wrapped in a cylindrical paper casing. Cigarette smoking is a cause of cough hypersensitivity syndrome as it irritates the airways, provokes inflammation, and damages lung tissues. For example, a report by Statistics Canada in July 2022 showed a 5.8% increase in cigarette production compared to June 2021 along with a 1.3% rise in the sales of cigarettes, reaching 1.4 billion in June 2022. Additionally, in May 2023, the Centers for Disease Control and Prevention estimated that around 28.3 million US adults were cigarette smokers and roughly 3.08 million U.S. middle and high school students used at least one tobacco product. An estimated 1,600 U.S. children under 18 years old start smoking every day. Consequently, the expanding population of cigarette smokers is likely to stimulate the growth of the cough hypersensitivity syndrome market.
Request Your Free Cough Hypersensitivity Syndrome Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12989&type=smp
Who Are the Major Companies Shaping the Competitive Landscape of the Cough Hypersensitivity Syndrome Market?
Major companies operating in the cough hypersensitivity syndrome market are:
• Pfizer Inc._x000D_
• Johnson and Johnson Ltd._x000D_
• F. Hoffmann-La Roche AG_x000D_
• Bayer AG_x000D_
• Novartis AG_x000D_
What Are the Key Emerging Trends in the Cough Hypersensitivity Syndrome Market for the Next Decade?
Leading businesses in the cough hypersensitivity syndrome market are concentrating their efforts on advancing their asthma treatment pipelines, particularly in the area of asthma rescue inhalers, with the intention of enhancing patient health outcomes and improving overall quality of life. These portable delivery systems provide rapid-reacting medication designed to open airways swiftly and effectively, potentially reducing sudden coughing incidents by providing temporary relief from the sensitivity of the airways and easing cough-related airway blockages. A prime example of this happened in April 2024, when Israeli Pharmaceutical firm Teva Pharmaceutical Industries Ltd. initiated a collaborative partnership with US-based clinical development company, Launch Therapeutics. Their shared objective is to expedite the clinical research program for their conjoint project, an inhaled corticosteroid and short-acting beta-agonist (ICS-SABA) inhaler called TEV-‘248. This inhaler utilises a combination of fluticasone propionate and albuterol sulfate, intended for both adult and pediatric asthma patients, while also aiming to decrease dependency on generic alternatives.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Core Categories and Segments in the Cough Hypersensitivity Syndrome Market Driving Demand and Growth?
The cough hypersensitivity syndrome market covered in this report is segmented –
1) By Drug Class: Inhales Corticosteroids, Antitussive Agents, Short-acting Beta-2 Agonists, Anticholinergics, Proton Pump Inhibitors, Antihistamines, Other Drugs
2) By Route of Administration: Oral, Inhalation, Other Route Of Administration
3) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Inhaled Corticosteroids: Budesonide, Fluticasone, Beclomethasone
2) By Antitussive Agents: Dextromethorphan, Codeine, Benzonatate
3) By Short-acting Beta-2 Agonists: Albuterol, Levalbuterol
4) By Anticholinergics: Ipratropium Bromide, Tiotropium
5) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole
6) By Antihistamines: Cetirizine, Loratadine, Diphenhydramine
7) By Other Drugs: Mucolytics, Combination Therapy Drugs
Which Regions Are Making a Mark in the Cough Hypersensitivity Syndrome Market Growth?
North America was the largest region in the cough hypersensitivity syndrome market in 2024. The regions covered in cough hypersensitivity syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Cough Hypersensitivity Syndrome Market Categorized and Defined in the Industry?
Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD) and upper airway disorders.
Browse Through More Similar Reports By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024
Respiratory Disposables Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
